...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: .0001

The trade was at .0001. That's 1/100th of a cent.  And the volume according to my brokerage was 4,360 shares. I don't see much chance somebody actually sold shares for 1/100th of a cent.  The commissions would swamp that.  If someone did, it wouldn't be anything more than an attempt to freak a few people out IMO.  Yo fuzzy, still think I'm short at 1/100th of a cent?  LOL.

Share
New Message
Please login to post a reply